Search

everythinglearnresearchcommunity

for

Search:↓

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

LGR6+ stem cells may improve bone healing.

Apple 'Hirosaki' callus extracts may improve wrinkles, stimulate hair growth, and have anti-inflammatory effects for use in cosmetics.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Skin has a larger surface area than thought, certain skin cells improve skin flap survival, better trials for skin conditions in children are needed, Stevens-Johnson syndrome rates vary by age and race, and better skin barrier function may reduce inflammation in the elderly.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Ferulic acid helps stabilize vitamins C and E for better skin protection from the sun, certain compounds may promote hair growth, atopic dermatitis patients have lower skin defense molecules, older men are more likely to get a type of skin cancer, and a substance called relaxin may prevent age-related skin thickening.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Damage to skin releases dsRNA, which activates TLR3 and helps in skin and hair follicle regeneration.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.